- Home
- CFBK vs MIST Comparison
CFBK vs MIST Comparison
Compare CFBK & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFBK
- MIST
- Stock Information
- Founded
- CFBK 1892
- MIST 2003
- Country
- CFBK United States
- MIST Canada
- Employees
- CFBK N/A
- MIST N/A
- Industry
- CFBK Major Banks
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- CFBK Finance
- MIST Health Care
- Exchange
- CFBK Nasdaq
- MIST Nasdaq
- Market Cap
- CFBK 159.5M
- MIST 145.3M
- IPO Year
- CFBK 1998
- MIST N/A
- Fundamental
- Price
- CFBK $24.12
- MIST $2.01
- Analyst Decision
- CFBK Buy
- MIST Strong Buy
- Analyst Count
- CFBK 1
- MIST 3
- Target Price
- CFBK $29.00
- MIST $6.33
- AVG Volume (30 Days)
- CFBK 32.8K
- MIST 1.2M
- Earning Date
- CFBK 10-29-2025
- MIST 11-11-2025
- Dividend Yield
- CFBK 1.32%
- MIST N/A
- EPS Growth
- CFBK 36.66
- MIST N/A
- EPS
- CFBK 2.77
- MIST N/A
- Revenue
- CFBK $52,793,000.00
- MIST N/A
- Revenue This Year
- CFBK $39.98
- MIST N/A
- Revenue Next Year
- CFBK $10.47
- MIST N/A
- P/E Ratio
- CFBK $8.73
- MIST N/A
- Revenue Growth
- CFBK 20.91
- MIST N/A
- 52 Week Low
- CFBK $19.23
- MIST $0.63
- 52 Week High
- CFBK $31.17
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- CFBK 47.27
- MIST 60.32
- Support Level
- CFBK $23.65
- MIST $2.03
- Resistance Level
- CFBK $24.44
- MIST $2.29
- Average True Range (ATR)
- CFBK 0.37
- MIST 0.09
- MACD
- CFBK -0.05
- MIST 0.00
- Stochastic Oscillator
- CFBK 38.16
- MIST 46.34
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).